Hematopoietic stem cell transplantation for multiple sclerosis: finding equipoise
- 1 August 2003
- journal article
- review article
- Published by Springer Nature in Bone Marrow Transplantation
- Vol. 32 (S1) , S45-S48
- https://doi.org/10.1038/sj.bmt.1703942
Abstract
Hematopoietic stem cell transplantation of multiple sclerosis is rapidly expanding. Success for this approach requires an understanding of the pathophysiology of multiple sclerosis and design of trials that select patients with active inflammatory disease, low disability scores, and avoidance of conditioning agents that may damage neural stem cell compartments or further compromise already injured axons.Keywords
This publication has 28 references indexed in Scilit:
- Multiple SclerosisNew England Journal of Medicine, 2000
- T cell-depleted autologous hematopoietic stem cell transplantation for multiple sclerosis: report on the first three patientsBone Marrow Transplantation, 1998
- Axonal Transection in the Lesions of Multiple SclerosisNew England Journal of Medicine, 1998
- The Natural History of Multiple Sclerosis: Update 1998Seminars in Neurology, 1998
- Axonal damage in acute multiple sclerosis lesionsBrain, 1997
- [13] Murine experimental autoimmune encephalomyelitis: A model of immune-mediated inflammation and multiple sclerosisPublished by Elsevier ,1997
- Interferon beta‐lb in the treatment of multiple sclerosisNeurology, 1995
- Natural history of multiple sclerosisAnnals of Neurology, 1994
- Interferon beta‐1b is effective in relapsing‐remitting multiple sclerosisNeurology, 1993
- HISTOCOMPATIBILITY DETERMINANTS IN MULTIPLE SCLEROSIS, WITH SPECIAL REFERENCE TO CLINICAL COURSEThe Lancet, 1973